Esperion Therapeutics Inc
SWB:0ET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Esperion Therapeutics Inc
SWB:0ET
|
US |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
K
|
Kohls Corp
XMUN:KHP
|
US |
|
W
|
Wartsila Oyj Abp
DUS:MTA
|
FI |
|
B
|
Ballard Power Systems Inc
DUS:PO0
|
CA |
Wall St Price Targets
0ET Price Targets Summary
Esperion Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0ET is 2.559 EUR with a low forecast of 1.551 EUR and a high forecast of 2.971 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0ET's stock price target?
Price Target
2.559
EUR
According to Wall Street analysts, the average 1-year price target for 0ET is 2.559 EUR with a low forecast of 1.551 EUR and a high forecast of 2.971 EUR.
What is the Revenue forecast for Esperion Therapeutics Inc?
Projected CAGR
3%
The compound annual growth rate for Revenue over the next 8 years is 3%.
What is the Gross Profit forecast for Esperion Therapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Gross Profit over the next 5 years is 29%.
What is the Operating Income forecast for Esperion Therapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 8 years is 28%.
